Science
Mechanism of Action
This peptide acts as a high-affinity ligand for Epidermal Growth Factor Receptors (EGFR), signaling fibroblasts and keratinocytes to initiate cellular migration and the synthesis of Type I collagen and elastin. Its unique molecular structure, derived from the thermophilic bacterium Tepidamorphus gemmatus, ensures the peptide remains active in various conditions, while the Baicalinoyl component neutralizes oxidative stress that typically degrades growth factors.
Research
Clinical Evidence
High confidence1%
Key findings
- 01 A 28-day clinical trial using a 1.0% concentration demonstrated a 24% decrease in wrinkle depth and a 19% improvement in periorbital dark circles.
- 02 Comparative in vitro analysis shows this extremophile-derived variant significantly outperforms standard recombinant human EGF in stimulating collagen synthesis and cellular repair rates.
Transparency
Dusting Analysis
Due to its high manufacturing cost and extreme potency, brands often include it at negligible levels (below 0.1%) for marketing claims. Efficacy requires at least 0.5% for visible regenerative results.
The Formula
Formulation
Stability
Exhibits remarkable thermal stability (up to 50°C) compared to traditional peptides. Often utilized within liposomal delivery systems like EPC Factor to ensure deep follicular and transdermal penetration.
Synergies
- Hyaluronic Acid
- Phospholipids
- Non-proteolytic peptides
Conflicts
- Proteolytic enzymes (Papain, Bromelain)
- Strong acids (pH < 4.0)
- Strong bases (pH > 9.0)
- High electrolyte concentrations
Safety
Safety Profile
While the specific conjugate is awaiting CIR review, the core components (Oligopeptide-1 and Baicalin) have extensive safety profiles and are EU CosIng compliant.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A superior, highly stable alternative to standard EGF that provides measurable structural rejuvenation and antioxidant defense.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources